DE1543966A1 - Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates - Google Patents

Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates

Info

Publication number
DE1543966A1
DE1543966A1 DE19661543966 DE1543966A DE1543966A1 DE 1543966 A1 DE1543966 A1 DE 1543966A1 DE 19661543966 DE19661543966 DE 19661543966 DE 1543966 A DE1543966 A DE 1543966A DE 1543966 A1 DE1543966 A1 DE 1543966A1
Authority
DE
Germany
Prior art keywords
new
preparation
thiamphenicol
compound
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661543966
Other languages
German (de)
English (en)
Inventor
Uberto Teotino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitefin Holding SA
Original Assignee
Whitefin Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitefin Holding SA filed Critical Whitefin Holding SA
Publication of DE1543966A1 publication Critical patent/DE1543966A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Temperature Or Quantity Of Heat (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19661543966 1965-03-29 1966-03-17 Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates Pending DE1543966A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR11035A FR4338M (cg-RX-API-DMAC10.html) 1965-03-29 1965-03-29

Publications (1)

Publication Number Publication Date
DE1543966A1 true DE1543966A1 (de) 1970-02-12

Family

ID=8575087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661543966 Pending DE1543966A1 (de) 1965-03-29 1966-03-17 Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates

Country Status (14)

Country Link
US (1) US3542854A (cg-RX-API-DMAC10.html)
AT (1) AT262260B (cg-RX-API-DMAC10.html)
BE (1) BE677985A (cg-RX-API-DMAC10.html)
BR (1) BR6678278D0 (cg-RX-API-DMAC10.html)
CH (1) CH449654A (cg-RX-API-DMAC10.html)
DE (1) DE1543966A1 (cg-RX-API-DMAC10.html)
DK (1) DK113359B (cg-RX-API-DMAC10.html)
ES (1) ES324795A1 (cg-RX-API-DMAC10.html)
FI (1) FI44626C (cg-RX-API-DMAC10.html)
FR (1) FR4338M (cg-RX-API-DMAC10.html)
GB (1) GB1064970A (cg-RX-API-DMAC10.html)
IL (1) IL25338A (cg-RX-API-DMAC10.html)
NL (2) NL6603885A (cg-RX-API-DMAC10.html)
NO (1) NO117797B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188402A (en) * 1977-08-05 1980-02-12 Clesa S.P.A. Derivatives of the D-threo-1-phenyl-2-trifluoroacetamido-1,3-propandediol
ITMI20021405A1 (it) * 2002-06-25 2003-12-29 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR11119E (fr) * 1905-03-28 1909-12-09 Andre Petit Cessionnaire Pompe ou moteur à piston annulaire
US3100781A (en) * 1957-11-20 1963-08-13 Zambon Spa Chloramphenicol glycinate and the production thereof
US3190910A (en) * 1958-06-26 1965-06-22 Parke Davis & Co Process for the production of threo-1-p-nitrophenyl-2-dichloroacetamido-3-aminoacetoxypropan-1-ol and its salts
US3000922A (en) * 1958-08-11 1961-09-19 Parke Davis & Co Quaternary salts of chloramphenicol esters of amino acids
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
NL130756C (cg-RX-API-DMAC10.html) * 1964-03-02

Also Published As

Publication number Publication date
IL25338A (en) 1969-09-25
US3542854A (en) 1970-11-24
ES324795A1 (es) 1967-02-01
AT262260B (de) 1968-06-10
NL6603885A (cg-RX-API-DMAC10.html) 1966-09-30
NO117797B (cg-RX-API-DMAC10.html) 1969-09-29
FI44626C (fi) 1971-12-10
GB1064970A (en) 1967-04-12
CH449654A (fr) 1968-01-15
DK113359B (da) 1969-03-17
FR4338M (cg-RX-API-DMAC10.html) 1966-08-08
BR6678278D0 (pt) 1973-09-11
NL128579C (cg-RX-API-DMAC10.html)
FI44626B (cg-RX-API-DMAC10.html) 1971-08-31
BE677985A (cg-RX-API-DMAC10.html) 1966-09-01

Similar Documents

Publication Publication Date Title
EP0289512B1 (de) Verfahren zur verbesserung der haftfähigkeit von gelen auf der schleimhaut
DE69018092T2 (de) Aerosolzubereitung von glutathion und verfahren zur erhöhung des glutathionspiegels in der lunge.
DE3427797A1 (de) Zytoprotektive wirkung von prostacyclin-derivaten an leber, bauchspeicheldruese und niere
DE1543966A1 (de) Verfahren zur Herstellung eines neuen Thiamphenikol-Derivates
WO2002022118A1 (de) Fungizides mittel enthaltend n-chlortaurin sowie dessen verwendung
JPS62103022A (ja) 化学療法剤の副作用低減化剤
DE102005053926B3 (de) Verwendung eines antibakteriellen Mittels aus einer Mischung aus Pflanzendrogen oder Extrakten daraus
DE2738652B2 (de) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
EP0912172B1 (de) Kombination aus cis-4-hydroxy-l-prolin und n-methyl-cis-4-hydroxy-l-prolin zur anwendung als therapeutischer wirkstoff insbesondere für die krebstherapie
DE1543150C (de) Tetracyclin-guajakol-4-su\fonat und Verfahren zu dessen Herstellung
DE627813C (de) Verfahren zur Herstellung eines desinfizierend wirkenden Mittels zum Schutz der Hautgegen Infektionen und zur Abheilung von Hautkrankheiten
DE1543966C (de) Thiamphenikol Derivat und Verfahren zu dessen Herstellung
DE69310565T2 (de) Verwendung von Bilobalid und deren Derivate zur Behandlung von Infektionen bei Menschen und für eine solche Anwendung geeignete pharmazeutische Zusammensetzung
DE3116695A1 (de) "neues pflanzenextrakt und ein dieses enthaltendes arzneimittel und dessen anwendung sowie verfahren zur herstellung des extrakts"
AT330953B (de) Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
DE2265235A1 (de) Heilmittel
DE10027474A1 (de) Pharmazeutische Zubereitung, umfassend Meerwasser und mindestens ein alpha-Sympathomimetikum
DE3007226A1 (de) Arzneikapsel
DE2358123A1 (de) Infusionsmaterial und verfahren zu seiner herstellung
DE2015877A1 (de) Arzneimittel
DE745419C (de) Verfahren zur Herstellung eines spezifischen Heilmittels gegen Hautekzeme
Madani et al. Ligation of the bile duct and acute chloroform toxicity in the donkey
DE1468665C (de) Tetracyclinmonopentachlorphenolat Verfahren zu dessen Herstellung und dieses enthaltende Heilmittel. Ausscheidung aus·. 1443126
AT77319B (de) Verfahren zur Darstellung von wasserlöslichen Verbindungen des Cystins und dessen Derivaten mit Desinfizientien zur Bekämpfung von Typhus und anderen Infektionskrankheiten, die in der Leber ihrer Ursprung haben.
CH713095B1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Entzündungen.

Legal Events

Date Code Title Description
E77 Valid patent as to the heymanns-index 1977